Mouse models for investigating the developmental basis of human birth defects

Pediatric Research

Volumn 59, Issue 6, 2006, Pages 749-755

  Moon, Anne M ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CRK LIKE PROTEIN; FIBROBLAST GROWTH FACTOR 8;

BIRTH DEFECT; CHROMOSOME 22Q; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; DIGEORGE SYNDROME; DISEASE MODEL; ECTODERM; EMBRYO DEVELOPMENT; EMBRYO MORTALITY; ENDODERM; GENE DELETION; GENE DISRUPTION; GENE INTERACTION; GENE TARGETING; GENETIC TRANSDUCTION; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM DEFECT; LETHALITY; MOLECULAR INTERACTION; MORPHOGENESIS; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; ORTHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROGENY; REVIEW; ANIMAL; ARTICLE; CHROMOSOME 22; CHROMOSOME DELETION; CONGENITAL MALFORMATION; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; MUTAGENESIS; PHENOTYPE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ABNORMALITIES; ANIMALS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 8; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 33746518105     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000218420.00525.98     Document Type: Review

References (40)

1. Capecchi MR 1994 Targeted gene replacement. Sci Am 270:52-59
2. De Moerlooze L, Dickson C 1997 Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr Opin Genet Dev 7:378-385
3. 2a. Basilico C (ed) 2005 Cytokine and Growth Factors Review, vol 16, Fibroblast Growth Factors, pp 105-247
4. Crossley PH, Martin GR 1995 The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121:439-451
5. Meyers EN, Lewandoski M, Martin GR 1998 An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141
6. Sun X, Meyers EN, Lewandoski M, Martin GR 1999 Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev 13:1834-1846
7. Frank DU, Fotheringham LK, Brewer JA, Muglia LJ, Tristani-Firouzi M, Capecchi MR, Moon AM 2002 An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129:4591-4603
8. Moon AM, Guris DL, Seo J, Li L, Hammond J, Talbot A, Imamoto A 2006 Crkl deficiency disrupts Fgf8 signaling in the pathogenesis of human 22q11 deletion syndromes. Dev Cell 10:71-80
9. Olson EN, Arnold HH, Rigby PW, Wold BJ 1996 Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85:1-4
10. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN 2002 a Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129:4613-4625
11. Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A 2001 Mice lacking the homologue of the human 22q11.2 gene Crkl phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27:293-298
12. Feller SM 2001 Crk family adaptors-signalling complex formation and biological roles. Oncogene 20:6348-6371
13. Li L, Guris DL, Okura M, Imamoto A 2003 Translocation of Crkl to focal adhesions mediates integrin-induced migration downstream of Src family kinases. Mol Cell Biol 23:2883-2892
14. Macatee TL, Hammond BP, Arenkiel BR, Francis L, Frank DU, Moon AM 2003 Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived Fgf8 during cardiovascular and pharyngeal development. Development 130:6361-6374
15. Dailey L, Ambrosetti D, Mansukhani A, Basilico C 2005 Mechanisms underlying differential responses to Fgf signaling. Cytokine Growth Factor Rev 16:233-247
16. Echevarria D, Belo JA, Martinez S 2005 Modulation of Fgf8 activity during vertebrate brain development. Brain Res Brain Res Rev 49:150-157
17. Sivak JM, Petersen LF, Amaya E 2005 Fgf signal interpretation is directed by Sprouty and Spred proteins during mesoderm formation. Dev Cell 8:689-701
18. Tsang M, Dawid IB 2004 Promotion and attenuation of Fgf signaling through the Ras-MAPK pathway. Sci STKE pe17.
19. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R 2003 Role of Tbx1 in human del22q11.2 syndrome. Lancet 362:1366-1373
20. Jerome LA, Papaioannou VE 2001 DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286-291
21. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, Baldini A 2001 Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101
22. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, Jore BS, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler P, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R 2001 Tbx1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-629
23. Guris DL, Duester G, Papaioannou VE, Imamoto A 2006 Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell 10:81-92
24. Vitelli F, Taddei I, Morishima M, Meyers EN, Lindsay EA, Baldini A 2002 A genetic link between Tbx1 and fibroblast growth factor signaling. Development 129:4605-4611
25. Byrd NA, Meyers EN 2005 Loss of Gbx2 results in neural crest cell patterning and pharyngeal arch artery defects in the mouse embryo. Dev Biol 284:233-245
26. Hu T, Yamagishi H, Maeda J, McAnally J, Yamagishi C, Srivastava D 2004 Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131:5491-5502
27. Sternberg N, Hamilton D 1981 Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150:467-486
28. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F 1996 Conditional gene targeting. J Clin Invest 98:600-603
29. Moon AM, Boulet AM, Capecchi MR 2000 Normal limb development in conditional mutants of Fgf4. Development 127:989-996
30. Moon AM, Capecchi MR 2000 Fgf8 is required for outgrowth and patterning of the limbs. Nat Genet 26:455-459
31. Farley FW, Soriano P, Steffen LS, Dymecki SM 2000 Widespread recombinase expression using FLPeR (Flipper) mice. Genesis 28:106-110
32. Boulet AM, Moon AM, Arenkiel BR, Capecchi MR 2004 The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev Biol 273:361-372
33. Lewandoski M, Sun X, Martin GR 2000 Fgf8 signalling from the AER is essential for normal limb development. Nat Genet 26:460-463
34. Sun X, Lewandoski M, Meyers EN, Liu YH, Maxson RE Jr., Martin GR 2000 Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat Genet 25:83-86
35. Sun X, Mariani FV, Martin GR 2002 Functions of Fgf signalling from the apical ectodermal ridge in limb development. Nature 418:501-508
36. de la Cruz MV, Markwald RR, Krug EL, Rumenoff L, Sanchez Gomez C, Sadowinski S, Galicia TD, Gomez F, Salazar Garcia M, Villavicencio Guzman L, et al 2001 Living morphogenesis of the ventricles and congenital pathology of their component parts. Cardiol Young 11:588-600
37. Harvey RP 2002 Patterning the vertebrate heart. Nat Rev Genet 3:544-556
38. Park E, Ogden LA, Talbot A, Evans S, Cai C, Black BL, Frank DV, Moon AM 2006 Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development, in press
39. Ornitz D, Xu J, Colvin J, McEwen D, MacArthur C, Coulier F, Gao G, Goldfarb M 1996 Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297
40. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2:reviews 3005.1-3005:12.